CRVS Market Cap & Key Metrics
Corvus Pharmaceuticals, Inc.
$9.86
+$0.48(+5.12%)
32
Overall
40
Value
18
Tech
39
Quality
Market Cap
$789.05M
Volume
395.30K
52W Range
$6.39 - $26.95
Target Price
$33.14
CRVS market cap is $789.05M. This page lists Corvus Pharmaceuticals, Inc.'s P/E ratio, EPS estimates, dividend yield, payout ratio and MarketXLS scores.
CRVS Key Metrics
- Market cap
- $789.05M
- EPS estimate, current year
- $-0.79
- EPS growth, 3-year
- +40.23%
- Value score
- 40
- Quality score
- 39
- Technical score
- 18
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| EBITDA | -$15.18M | -$62.21M | -$26.88M | -$40.94M | -$38.17M |
| EPS | $-0.19 | $-1.02 | $-0.56 | $-0.89 | $-1.03 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CRVS | $9.86 | +5.1% | 395.30K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Corvus Pharmaceuticals, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW